Here's a real-world comparison of the weight loss data we have: Semaglutide 2.4 mg (Wegovy): ~15% body weight loss at 68 weeks in the STEP 1 trial Tirzepatide 15 mg (Zepbound): ~22.5% body weight loss at 72 weeks in SURMOUNT-1 Retatrutide 12 mg: ~24.2% body weight loss at 48 weeks in Phase 2 (shorter trial, remember) Promising, but still unproven at scale
10.1016/S0891-5849(99)00229-4 16 BraigD.NeroT
I have no idea how many milligrams are in the unit, especially if they are mixing it with other ingredients. Salt Forms Its unclear if these salt forms have different chemical and pharmacologic properties that could impact their safety and effectiveness
While these side effects are generally mild and transient, informing your doctor promptly can help address any issues and ensure that you can continue treatment safely
Its injection is a compounded form of semaglutide, the medicine sold by Novo Nordisk as Ozempic and Wegovy, which remains on the FDA's shortage list
Some individuals see lower blood sugar readings after just a dose or two, while others may need several weeks of consistent use before experiencing significant changes